(Press-News.org) Chemotherapy is associated with an increased risk of treatment-related heart damage, including heart failure and cerebrovascular disease, for many patients. But a new meta-analysis, presented at the American College of Cardiology’s Advancing the Cardiovascular Care of the Oncology Patient 2023 conference, finds that Black patients or patients of African ancestry have 71% higher odds of cardiotoxicity following cancer treatment compared to White patients.
Cardiotoxicity is any heart damage stemming from cancer treatment or drugs, including chemotherapy agents and radiation. It can lead to several heart problems, including heart failure, cardiomyopathy and irregular heart rhythms. Certain cancer treatments have a higher risk of causing cardiotoxicity, including anthracyclines, which are used to treat leukemias, lymphomas, and cancers of the breast, stomach, uterus, ovary and lung.
“Unfortunately, we were not surprised [by the findings]. Research shows that Black patients have poorer outcomes for almost every disease,” said Wondewossen Gebeyehu, BSc, a medical student at the University of Toronto and lead author of the study. “In this case, one could have expected that the differences would be minimal since it is the chemotherapy that is injuring the heart, and we would expect the same chemotherapy to be given to Black and non-Black patients with a given cancer. However, this systematic review indicates that the inequities in health outcomes extends to the odds of cardiotoxicity after cancer treatment.”
Researchers performed a systematic search of several databases—including Medline, Embase, Pubmed and others—of all studies reporting on cardiovascular toxicity in cancer patients of different racial/ethnic background receiving chemotherapy. After screening 7,057 studies, 24 studies representing 683,749 participants were included in the final review. Black race or African ancestry was associated with 71% increased odds of chemotherapy-associated cardiotoxicity; it was also associated with increased odds of a congestive heart failure diagnosis.
“These results may reflect the direct effects of racism, particularly structural racism, which leads to worse determinants of health for Black patients. It is well-documented that most health care settings are not perceived as safe by Black patients, which may increase their vulnerability to disease and decrease opportunities for preventative care,” Gebeyehu said. “Furthermore, decreased representation of Black patients in clinical trials may lead to treatments being developed that are not as effective or which may be riskier for Black patients. Importantly, these results should prompt further inquiry into the many possible contributors to disparities observed in Black patients.”
According to the researchers, the study quantifies the increased odds of chemotherapy-associated cardiotoxicity for Black cancer patients. The study also highlights the need for further study to determine underlying factors contributing to these disparities so they can be reduced.
“The most important message for patients is that they should not avoid chemotherapy, as the most important thing is making sure they get the best cancer treatment possible, and studies already show Black patients may get less optimal cancer treatments,” Gebeyehu said. “For clinicians, it is important to be aware of these higher odds of cardiotoxicity faced by Black patients. Understanding these disparities will hopefully lead to clinicians having more conversations around reducing cardiovascular risk associated with chemotherapy and targeted efforts to cater to groups at higher risk.”
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. As the preeminent source of professional medical education for the entire cardiovascular care team since 1949, ACC credentials cardiovascular professionals in over 140 countries who meet stringent qualifications and leads in the formation of health policy, standards and guidelines. Through its world-renowned family of JACC Journals, NCDR registries, ACC Accreditation Services, global network of Member Sections, CardioSmart patient resources and more, the College is committed to ensuring a world where science, knowledge and innovation optimize patient care and outcomes. Learn more at www.ACC.org or follow @ACCinTouch.
###
END
WASHINGTON—On World Quantum Day, Optica Publishing Group announced it will begin publishing a new journal in September 2023 dedicated to highly selective results in quantum information science and technology (QIST). The new journal, Optica Quantum, joins the Society’s portfolio of the most-cited journals in optics and photonics and will provide the community with articles of the same exceptional standards for quality, novelty, and significance as its parent journal, Optica.
The concept of quantum light serves as a foundation for many quantum technologies and ongoing ...
The alnus ambrosia beetle Xylosandrus germanus, also known as the black stem borer, was accidentally introduced by humans from its native east Asia to North America and Europe around the beginning of the 20th century. X. germanus is a so-called ambrosia beetle, which means that it farms its own food: a specialized fungal symbiont which it ‘sows’ and tends inside the galleries that it digs inside wood. It is a destructive invasive pest, known to attack more than 200 species from 51 families of broadleaf and conifer trees. While it prefers to colonize dead ...
The demand for precious metals and rare earths is expected to continue increasing in the future. Due to limited production areas, recycling from precision equipment and recovering from seawater and hot spring water are needed to ensure a stable supply.
A research group led by Professor Masayuki Azuma and Associate Professor Yoshihiro Ojima of the Osaka Metropolitan University Graduate School of Engineering has successfully developed an adsorbent material that can selectively recover rare earth elements (REEs) using environmentally friendly and inexpensive baker’s yeast and trimetaphosphate, which is used as a food additive.
The research group conducted experiments using ...
**Note: the release below is from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2023, Copenhagen, 15-18 April). Please credit the conference if you use this story**
Did the recent mpox (formerly known as monkeypox) outbreak end because of “network immunity”? That’s the theory being put forward by Belgian researchers at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April).
2022 saw a global outbreak of mpox, a viral ...
Peer-reviewed / Observational study / People
The Lancet Public Health: Hearing aids may protect against a higher risk of dementia associated with hearing loss, study suggests
Study of 437,704 people suggests those experiencing hearing loss and not using hearing aids may have a higher risk of dementia than people without hearing loss. Those using hearing aids did not appear to be at an increased risk of dementia.
After adjusting for other factors, study analysis suggests a 1.7% risk of dementia in people with hearing loss who are not using hearing aids, compared to 1.2% among those without hearing loss ...
*Note: this is a joint press release from the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and The Lancet Infectious Diseases. Please credit both the congress and the journal in your stories*
Since September, 2022, bivalent mRNA vaccines – which contain elements from both the original wild type COVID strain and an updated component from the omicron strain – have replaced older style monovalent boosters in the USA, Israel, and other countries. These vaccines were designed to help improve vaccine-induced immunity against the omicron variant and subsequent subvariants.
A new study published in The Lancet Infectious Diseases and ...
Adding fuel to The University of Texas at Austin’s startup engine, alumnus William “Billy” Freed, BBA ’81, and his family have given $1 million to the Herb Kelleher Entrepreneurship Center in the McCombs School of Business.
The gift establishes the Freed Family Entrepreneurship Excellence Fund and endows the Freed Family Pitch Competition, previously called DisrupTexas. Freed’s wife Cheryl, BA ’82, JD ’84; sons Tyler, BS ’17, and Russell, BBA ’21; and daughter-in-law Leslie Lugrin Freed, BS ’17, ...
How can Marvel movie character Ant-Man produce such strong energy out of his small body? The secret lies in the “transistors” on his suit that amplify weak signals for processing. Transistors that amplify electrical signals in the conventional way lose heat energy and limit the speed of signal transfer, which degrades performance. What if it were possible to overcome such limitation and make a high-performance suit that is light and small but without loss of heat energy?
A POSTECH team of Professor Kyoung-Duck Park and Yeonjeong Koo from the Department of Physics and a team from ...
PITTSBURGH, April 13, 2023 – In a paper published today in Molecular Psychiatry, a team of scientists from the University of Pittsburgh in collaboration with researchers in Italy described shared patterns of sleep disturbances and irregularities in daily rhythms of rest and activity across patients with schizophrenia spectrum disorder, or SSD.
By using wrist monitors that measured activity and rest as proxies of wakefulness and sleep, researchers found that individuals with SSD who resided in psychiatric hospitals and those who manage their condition in outpatient settings had erratic sleep patterns, dysregulated transitions between sleep ...
A stop smoking mobile app that senses where and when you might be triggered to light up could help people quit – according to University of East Anglia research.
Quit Sense is the world’s first Artificial Intelligence (AI) stop smoking app which detects when people are entering a location they used to smoke in. It then provides support to help manage people’s specific smoking triggers in that location.
Funding for the Quit Sense app has come from the National Institute for Health and Care Research (NIHR) and the Medical Research Council.
A study published today shows how the new ...
